Vactosertib |
TEW-7197; EW-7197; NOV-1301 |
Phase 3 Clinical |
Medpacto Inc |
Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Myelodysplastic Syndromes; Carcinoma, Transitional Cell; Myeloproliferative Disorders; Osteosarcoma; Colorectal Neoplasms; Urologic Neoplasms; Esophageal adenocarcinoma; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Melanoma |
Details
|
Bintrafusp alfa |
M-7824; GSK-4045154; MSB-0011359C |
Phase 3 Clinical |
Merck Serono |
Lung Neoplasms; Sarcoma; Cholangiocarcinoma; Breast Neoplasms; Microsatellite Instability; Vulvar Neoplasms; Nasopharyngeal Carcinoma; Prostatic Neoplasms; Colorectal Neoplasms; Oropharyngeal Neoplasms; Thymus Neoplasms; Gallbladder Neoplasms; Adenomyoepithelioma; Lymphoma; Brain metastases; Urogenital Neoplasms; Thymoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Sarcoma, Kaposi; Triple Negative Breast Neoplasms; Solid tumours; Hematologic Neoplasms; Head and Neck Neoplasms; Intestinal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Rectal Neoplasms; Anus Neoplasms; Stomach Neoplasms; Carcinoma; Carcinoma, Renal Cell; Esthesioneuroblastoma, Olfactory; Biliary Tract Neoplasms; Neoplasms; Colonic Neoplasms; Small Cell Lung Carcinoma; Papillomavirus Infections; Carcinoma, Transitional Cell; Nose Neoplasms; Ganglioglioma; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Urinary Bladder Neoplasms |
Details
|
Nisevokitug |
NIS-793 |
Phase 3 Clinical |
Xoma Corp |
Kidney Neoplasms; Liver Neoplasms; Pancreatic Neoplasms; Myelodysplastic Syndromes; Small Cell Lung Carcinoma; Breast Neoplasms; Colorectal Neoplasms; Primary Myelofibrosis; Carcinoma, Pancreatic Ductal; Lung Neoplasms; Adenocarcinoma |
Details
|
SB-01 (Spine Biopharma) |
SB-01 |
Phase 3 Clinical |
Spine BioPharma Inc |
Intervertebral disc disease; Low Back Pain |
Details
|
Dalutrafusp alfa |
GS-1423; AGEN-1423 |
Phase 2 Clinical |
Agenus Inc |
Liver Neoplasms; Solid tumours; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal |
Details
|
ZSP-1603 |
ZSP-1603 |
Phase 2 Clinical |
Wuxi Apptec Co Ltd, Guangdong Zhongsheng Pharmaceutical Co Ltd |
Ovarian Neoplasms; Liver Neoplasms; Solid tumours; Carcinoma, Renal Cell; Colonic Neoplasms; Idiopathic Pulmonary Fibrosis; Thyroid Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Nicousamide |
XLF-III-43 |
Phase 2 Clinical |
Institue Of Materia Medica Chinese Academy Of Medical Science |
Hypertensive nephropathy; Diabetic Nephropathies |
Details
|
Meflonidone hydrochloride |
|
Phase 2 Clinical |
Guangzhou Nanxin Pharma Co Ltd, Central South University |
Diabetes Mellitus, Type 2; Diabetic Nephropathies |
Details
|
Fluorofenidone |
AKF-PD |
Phase 2 Clinical |
Dierepharma HK Ltd, Hainan Haiyao Co Ltd, Central South University |
Liver Cirrhosis |
Details
|
Cotsiranib |
STP-705LU; STP-705LV; STP-705; STP-705L |
Phase 2 Clinical |
Sirnaomics, Sirnaomics Biopharmaceuticals (Suzhou) Co Ltd |
Liver Neoplasms; Carcinoma, Basal Cell; Carcinoma, Basosquamous; Cholangiocarcinoma; Obesity, Abdominal; Keloid; Cicatrix, Hypertrophic; Carcinoma, Hepatocellular |
Details
|
Yinfenidone Hydrochloride |
HEC-585; HEC-00000585 |
Phase 2 Clinical |
Hec Pharm Co Ltd |
Idiopathic Pulmonary Fibrosis; Lung Diseases, Interstitial |
Details
|
YL-13027 |
YL-13027 |
Phase 2 Clinical |
YL-Pharma |
Solid tumours; Pancreatic Neoplasms |
Details
|
Linavonkibart |
SRK-181 |
Phase 1 Clinical |
Scholar Rock |
Neoplasms |
Details
|
Charis-1000 |
Charis-1000; C 1K; C1K |
Phase 1 Clinical |
|
Breast Neoplasms |
Details
|
HLX-6018 |
HLX-6018; HLX6018 |
Phase 1 Clinical |
Shanghai Henlius Biotech Inc |
Idiopathic Pulmonary Fibrosis |
Details
|
JYB-1907 |
JYB-1907 |
Phase 1 Clinical |
Jiangxi Jemincare Group Co Ltd |
Solid tumours |
Details
|
STP-707 |
STP-707 |
Phase 1 Clinical |
Sirnaomics Biopharmaceuticals (Suzhou) Co Ltd |
Solid tumours; Liver Neoplasms; Liver Cirrhosis; Pulmonary Fibrosis; Cholangitis, Sclerosing |
Details
|
PXS-64 |
PXS-64 |
Phase 1 Clinical |
|
Multiple Sclerosis |
Details
|
Livmoniplimab |
MGH-8; ARGX-115; AGRX-115; ABBV151 |
Phase 1 Clinical |
Argenx Se |
Carcinoma, Hepatocellular |
Details
|
AVID-200 |
AVID-200; BMS-986416; AVID-200 DP |
Phase 1 Clinical |
Formation Biologics Corp |
Solid tumours; Polycythemia Vera; Primary Myelofibrosis; Scleroderma, Diffuse; Thrombocythemia, Essential |
Details
|
Vactosertib |
TEW-7197; EW-7197; NOV-1301 |
Phase 3 Clinical |
Medpacto Inc |
Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Myelodysplastic Syndromes; Carcinoma, Transitional Cell; Myeloproliferative Disorders; Osteosarcoma; Colorectal Neoplasms; Urologic Neoplasms; Esophageal adenocarcinoma; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Melanoma |
Details
|
Bintrafusp alfa |
M-7824; GSK-4045154; MSB-0011359C |
Phase 3 Clinical |
Merck Serono |
Lung Neoplasms; Sarcoma; Cholangiocarcinoma; Breast Neoplasms; Microsatellite Instability; Vulvar Neoplasms; Nasopharyngeal Carcinoma; Prostatic Neoplasms; Colorectal Neoplasms; Oropharyngeal Neoplasms; Thymus Neoplasms; Gallbladder Neoplasms; Adenomyoepithelioma; Lymphoma; Brain metastases; Urogenital Neoplasms; Thymoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Sarcoma, Kaposi; Triple Negative Breast Neoplasms; Solid tumours; Hematologic Neoplasms; Head and Neck Neoplasms; Intestinal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Rectal Neoplasms; Anus Neoplasms; Stomach Neoplasms; Carcinoma; Carcinoma, Renal Cell; Esthesioneuroblastoma, Olfactory; Biliary Tract Neoplasms; Neoplasms; Colonic Neoplasms; Small Cell Lung Carcinoma; Papillomavirus Infections; Carcinoma, Transitional Cell; Nose Neoplasms; Ganglioglioma; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Urinary Bladder Neoplasms |
Details
|
Nisevokitug |
NIS-793 |
Phase 3 Clinical |
Xoma Corp |
Kidney Neoplasms; Liver Neoplasms; Pancreatic Neoplasms; Myelodysplastic Syndromes; Small Cell Lung Carcinoma; Breast Neoplasms; Colorectal Neoplasms; Primary Myelofibrosis; Carcinoma, Pancreatic Ductal; Lung Neoplasms; Adenocarcinoma |
Details
|
SB-01 (Spine Biopharma) |
SB-01 |
Phase 3 Clinical |
Spine BioPharma Inc |
Intervertebral disc disease; Low Back Pain |
Details
|
Dalutrafusp alfa |
GS-1423; AGEN-1423 |
Phase 2 Clinical |
Agenus Inc |
Liver Neoplasms; Solid tumours; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal |
Details
|
ZSP-1603 |
ZSP-1603 |
Phase 2 Clinical |
Wuxi Apptec Co Ltd, Guangdong Zhongsheng Pharmaceutical Co Ltd |
Ovarian Neoplasms; Liver Neoplasms; Solid tumours; Carcinoma, Renal Cell; Colonic Neoplasms; Idiopathic Pulmonary Fibrosis; Thyroid Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Nicousamide |
XLF-III-43 |
Phase 2 Clinical |
Institue Of Materia Medica Chinese Academy Of Medical Science |
Hypertensive nephropathy; Diabetic Nephropathies |
Details
|
Meflonidone hydrochloride |
|
Phase 2 Clinical |
Guangzhou Nanxin Pharma Co Ltd, Central South University |
Diabetes Mellitus, Type 2; Diabetic Nephropathies |
Details
|
Fluorofenidone |
AKF-PD |
Phase 2 Clinical |
Dierepharma HK Ltd, Hainan Haiyao Co Ltd, Central South University |
Liver Cirrhosis |
Details
|
Cotsiranib |
STP-705LU; STP-705LV; STP-705; STP-705L |
Phase 2 Clinical |
Sirnaomics, Sirnaomics Biopharmaceuticals (Suzhou) Co Ltd |
Liver Neoplasms; Carcinoma, Basal Cell; Carcinoma, Basosquamous; Cholangiocarcinoma; Obesity, Abdominal; Keloid; Cicatrix, Hypertrophic; Carcinoma, Hepatocellular |
Details
|
Yinfenidone Hydrochloride |
HEC-585; HEC-00000585 |
Phase 2 Clinical |
Hec Pharm Co Ltd |
Idiopathic Pulmonary Fibrosis; Lung Diseases, Interstitial |
Details
|
YL-13027 |
YL-13027 |
Phase 2 Clinical |
YL-Pharma |
Solid tumours; Pancreatic Neoplasms |
Details
|
Linavonkibart |
SRK-181 |
Phase 1 Clinical |
Scholar Rock |
Neoplasms |
Details
|
Charis-1000 |
Charis-1000; C 1K; C1K |
Phase 1 Clinical |
|
Breast Neoplasms |
Details
|
HLX-6018 |
HLX-6018; HLX6018 |
Phase 1 Clinical |
Shanghai Henlius Biotech Inc |
Idiopathic Pulmonary Fibrosis |
Details
|
JYB-1907 |
JYB-1907 |
Phase 1 Clinical |
Jiangxi Jemincare Group Co Ltd |
Solid tumours |
Details
|
STP-707 |
STP-707 |
Phase 1 Clinical |
Sirnaomics Biopharmaceuticals (Suzhou) Co Ltd |
Solid tumours; Liver Neoplasms; Liver Cirrhosis; Pulmonary Fibrosis; Cholangitis, Sclerosing |
Details
|
PXS-64 |
PXS-64 |
Phase 1 Clinical |
|
Multiple Sclerosis |
Details
|
Livmoniplimab |
MGH-8; ARGX-115; AGRX-115; ABBV151 |
Phase 1 Clinical |
Argenx Se |
Carcinoma, Hepatocellular |
Details
|
AVID-200 |
AVID-200; BMS-986416; AVID-200 DP |
Phase 1 Clinical |
Formation Biologics Corp |
Solid tumours; Polycythemia Vera; Primary Myelofibrosis; Scleroderma, Diffuse; Thrombocythemia, Essential |
Details
|